Variable | Valuea | Mortality at 1 mo | |
---|---|---|---|
OR (95% CI) | P value | ||
Sex | Â | Â | 0.287 |
 Male | 147 (62.03) | Reference |  |
 Female | 90 (37.97) | 1.44 (0.74, 2.83) |  |
Age, y | 67.91 ± 11.97 | 1.06 (1.02, 1.10) | 0.003 |
History of hypertension | 157 (66.24) | 1.54 (0.73, 3.26) | 0.256 |
History of diabetes | 34 (14.35) | 3.71 (1.68, 8.23) | 0.001 |
History of atrial fibrillation | 117 (49.37) | 1.65 (0.84, 3.24) | 0.149 |
History of coronary heart disease | 27 (11.39) | 0.79 (0.26, 2.41) | 0.675 |
History of stroke | 40 (16.88) | 0.62 (0.23, 1.68) | 0.347 |
History of chronic kidney disease | 5 (2.11) | 7.42 (1.20, 45.90) | 0.031 |
History of carotid artery disease | 8 (3.38) | 2.92 (0.67, 12.74) | 0.153 |
Current antiplatelet therapy | 22 (9.28) | 1.41 (0.49, 4.08) | 0.520 |
Current anticoagulation therapy | 16 (6.75) | 1.08 (0.29, 3.96) | 0.911 |
Systolic BP at admission, mmHg | 151.09 ± 24.43 | 1.00 (0.99, 1.02) | 0.807 |
Diastolic BP at admission, mmHg | 87.78 ± 14.46 | 0.99 (0.97, 1.02) | 0.520 |
Baseline NIHSS score | 15.30 ± 7.05 | 1.18 (1.12, 1.25) | < 0.001 |
ASPECTS | 8.02 ± 1.45 | 0.90 (0.72, 1.12) | 0.357 |
Glucose at admission | 7.76 ± 2.85 | 1.13 (1.02,1.25) | 0.017 |
Bridging intravenous thrombolysis | 24 (10.13) | 2.63 (1.04, 6.64) | 0.040 |
Favorable collateral circulation | 48 (20.25) | 0.36 (0.12, 1.07) | 0.066 |
Cardioembolic stroke | 141 (59.49) | 2.18 (1.04, 4.58) | 0.040 |
Internal carotid artery occlusion | 92 (38.82) | 1.96 (1.00, 3.85) | 0.049 |
Pneumonia during hospitalization | 98 (41.35) | 2.18 (1.11, 4.29) | 0.024 |
Urinary tract infection during hospitalization | 8 (3.38) | 2.92 (0.67, 12.74) | 0.153 |
Dialysis during hospitalization | 1 (0.70) | Inf.(0.00, Inf) | 0.991 |
Anticoagulation during hospitalization | 64 (27.00) | 0.17 (0.05, 0.57) | 0.004 |
Use of invasive mechanical ventilation during hospitalization | 51 (21.52) | 17.54 (7.96, 38.67) | < 0.001 |
Use of vasopressors during hospitalization | 32 (13.50) | 13.86 (5.98, 32.16) | < 0.001 |
Sepsis during hospitalization | 6 (2.53) | 10.16 (1.80, 57.45) | 0.001 |
Any intracerebral hemorrhage during hospitalization | 102 (43.04) | 4.92 (2.33, 10.39) | < 0.001 |
Symptomatic intracerebral hemorrhage during hospitalization | 19 (8.02) | 26.53 (8.20, 85.84) | < 0.001 |
NLR | |||
 At admission | 4.43 ± 3.71 | 1.08 (1.00, 1.17) | 0.0578 |
 Immediately after EVT | 8.59 ± 5.41 | 1.05 (0.99, 1.11) | 0.111 |
 Within 12–24 h after EVT | 10.03 ± 6.12 | 1.14 (1.07, 1.20) | < 0.001 |
 Within 24–48 h after EVT | 9.32 ± 5.27 | 1.13 (1.05, 1.22) | 0.002 |
 Within 48–72 h after EVT | 10.09 ± 5.93 | 1.22 (1.12, 1.33) | < 0.001 |